 Allergan Inc., has approached Salix Pharmaceuticals Ltd. about a potential acquisition that could thwart a $53 billion hostile bid for Allergan by Valeant Pharmaceuticals International Inc., according to people familiar with the matter.. While it is unclear where the talks stand, Allergan could strike a takeover deal with Salix or another unknown party as early as next month, one of the people said.. Signs...
  